Nasdaq· Bottled & Canned Soft Drinks & Carbonated Waters· Inc. X0· CIK 0001650107

CCEP

COCA-COLA EUROPACIFIC PARTNERS plc
$101.06 ▲ +0.27%
Prev close $100.79
Market cap$46.2B
ConsensusBuy
12-mo target$108.62 (+7.5%)
▲ Bullish
Analyst conviction 7/10
Consumer & Retail
Snapshot
The big-picture read on CCEP right now — valuation, ownership and activity at a glance.
Market Cap
$46.2B
Cap Size
Large Cap
Analyst Consensus
Buy (65%)
SEC Reports
20
Price chart 30d -7.4%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Analyst ratings buy % -11.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Buy 65% rate it Buy or better · 23 analysts
Strong Buy 4 17% Buy 11 48% Hold 6 26% Sell 1 4% Strong Sell 1 4%
Recent analyst actions
DateFirmActionRatingFirm rating
Aug 13, 2026UBSDOWNGRADENeutral 55%
Aug 6, 2026BarclaysMAINTAINOverweight 54%
Aug 5, 2026Evercore ISI GroupMAINTAINOutperform 59%
Aug 3, 2026Wells FargoMAINTAINOverweight 54%
Jul 21, 2026BarclaysMAINTAINOverweight 54%
Jul 8, 2026Wells FargoMAINTAINOverweight 54%
Jun 12, 2026Wells FargoINITIATEOverweight 54%
Apr 30, 2026BarclaysMAINTAINOverweight 54%
Apr 29, 2026UBSMAINTAINBuy 55%
Apr 14, 2026BarclaysMAINTAINOverweight 54%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 202641161165%
Aug 1, 202641241173%
Jul 1, 202641241173%
Jun 1, 202641141171%
May 1, 202641151168%
Apr 1, 202641160168%
Mar 1, 202641160168%
Feb 1, 202641160168%
Price targets
Where 12 covering analysts think CCEP trades over the next 12 months.
$108.62 +7.5% upside Buy
Current$101.06 Low$89.08 Median$112.37 High$117.26 12 analysts
$89.08$117.26
Analyst rating Buy· 1.9/5 as of Oct 2, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 0 bullish, 0 bearish, 0 mixed, 20 neutral · avg impact 2.6/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: CCEP — 56.7% short (0.4M / 0.6M)
Short: 365,105 | Exempt: 5,942 | TRF Vol: 644,478 | Short Ratio: 56.7% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: CCEP — 66.4% short (0.4M / 0.6M)
Short: 408,063 | Exempt: 0 | TRF Vol: 614,809 | Short Ratio: 66.4% | Off-exchange volume (dark pool + OTC)
Sep 23, 2026
short_volume
Short Volume: CCEP — 62.7% short (0.4M / 0.7M)
Short: 429,348 | Exempt: 5 | TRF Vol: 684,248 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Sep 18, 2026
short_volume
Short Volume: CCEP — 64.4% short (0.5M / 0.8M)
Short: 522,049 | Exempt: 39 | TRF Vol: 811,085 | Short Ratio: 64.4% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: CCEP — 59.7% short (0.7M / 1.1M)
Short: 679,524 | Exempt: 172 | TRF Vol: 1,138,421 | Short Ratio: 59.7% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$0.00$0.00–$0.00———$5.7B—
Next Q$0.00$0.00–$0.00———$5.3B—
Current FY$4.49$4.44–$4.564.9%-0.1%—$21.6B11
Next FY$4.91$4.79–$5.089.2%-0.1%2↑ 0↓$22.4B12
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CCEP.
Shares short
11,533,719
Settlement Sep 15, 2026
Change vs prior
+13.8%
Semi-monthly cycle
Days to cover
8.2
At avg daily volume
Of shares outstanding
≈2.5%
Estimate — not % of float
All CCEP filing & press-release reports (24)